Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ANGIOEDEMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01005888
What this trial is testing

C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

Who this might be right for
Hereditary Angioedema
Shire 26
Early research (Phase 1)Study completedNCT02093923
What this trial is testing

A Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Participants

Who this might be right for
Hereditary Angioedema (HAE)
Shire 38
Early research (Phase 1)Study completedNCT02218294
What this trial is testing

Study to Determine How BCX4161 is Metabolized and Eliminated by the Body

Who this might be right for
Hereditary Angioedema
BioCryst Pharmaceuticals 7
Large-scale testing (Phase 3)Active Not RecruitingNCT06634420
What this trial is testing

HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
Intellia Therapeutics 80
Not applicableStudy completedNCT04032002
What this trial is testing

Involvement of Monocytic B1 and B2 Receptors in Inflammation and Chronic Vascular Disease in Patients With Hereditary Bradykinetic Angioedema

Who this might be right for
Hereditary Bradykinetic Angioedema
University Hospital, Rouen 30
Large-scale testing (Phase 3)Study completedNCT05819775
What this trial is testing

CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
CSL Behring 22
Post-approval studies (Phase 4)Study completedNCT01457430
What this trial is testing

Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE

Who this might be right for
Hereditary Angioedema
Massachusetts General Hospital 19
Large-scale testing (Phase 3)Study completedNCT01188564
What this trial is testing

Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE Attacks

Who this might be right for
Hereditary Angioedema
Pharming Technologies B.V. 75
Large-scale testing (Phase 3)Study completedNCT00125151
What this trial is testing

C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema

Who this might be right for
Angioedema
Prothya Biosolutions 15
Testing effectiveness (Phase 2)Study completedNCT01154361
What this trial is testing

AMelioration of Angiotensin Converting Enzyme Inhibitor Induced Angioedema Study

Who this might be right for
Angioedema
Technical University of Munich
Not applicableStudy completedNCT03558009
What this trial is testing

Epidemiological Analysis for Hereditary Angioedema Disease

Who this might be right for
Abdominal PainFunctional Abdominal Pain
CENTOGENE GmbH Rostock 2,318
Not applicableLooking for participantsNCT07448181
What this trial is testing

Real-life Ecological Momentary Assessment of Lived Burden in Hereditary AngioEdema

Who this might be right for
Hereditary Angioedema With C1 Esterase Inhibitor DeficiencyHereditary Angioedema - Type 1Hereditary Angioedema - Type 2
Istituti Clinici Scientifici Maugeri SpA 30
Testing effectiveness (Phase 2)Study completedNCT04030598
What this trial is testing

Assess the Clinical Efficacy of Donidalorsen (Also Known as IONIS-PKK-LRx and ISIS 721744) in Participants With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Ionis Pharmaceuticals, Inc. 23
Large-scale testing (Phase 3)Study completedNCT05505916
What this trial is testing

An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 145
Early research (Phase 1)Study completedNCT02448264
What this trial is testing

First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BCX7353 in Healthy Western and Japanese Volunteers

Who this might be right for
Hereditary Angioedema
BioCryst Pharmaceuticals 122
Testing effectiveness (Phase 2)Study completedNCT03240133
What this trial is testing

Study of BCX7353 as a Treatment for Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
BioCryst Pharmaceuticals 58
Large-scale testing (Phase 3)Study completedNCT04687137
What this trial is testing

Expanded Access Program With Lanadelumab for Japanese People With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Takeda 12
Large-scale testing (Phase 3)Study completedNCT01912456
What this trial is testing

Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 90
Large-scale testing (Phase 3)Study completedNCT02584959
What this trial is testing

Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 75
Not applicableApproved For MarketingNCT03177005
What this trial is testing

Expanded Access for Hereditary Angioedema (HAE)

Joshua S. Jacobs, MD
Next Page